Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben George

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 16, 2014
Diagnostic laparoscopy should be performed before definitive resection for pancreatic cancer: a financial argumentThejus T Jayakrishnan, Hasan Nadeem, Ryan T Groeschl, et al.
Advances in Radiation Oncology|November 10, 2025
Safety and Efficacy of Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy (SMART) for Ultracentral Metastases in Non-Small Cell Lung CancerElena Moreno-Olmedo, Ben George, Kasia Owczarczyk, et al.
Annals of Surgery|October 13, 2018
Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic CancerSusan Tsai, Ben George, David Wittmann, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 2, 2020
Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancerAshley N Krepline, Jennifer L Geurts, Idayat Akinola, et al.
Surgery|July 6, 2019
Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgeryChad A Barnes, Mariana I Chavez, Susan Tsai, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 30, 2017
Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy?Chad A Barnes, Ashley N Krepline, Mohammed Aldakkak, et al.
Therapeutic Advances in Medical Oncology|May 21, 2024
Chemotherapy-free treatment targeting fusions and driver mutations in <i>KRAS</i> wild-type pancreatic ductal adenocarcinoma, a case seriesMaahum Mehdi, Aniko Szabo, Aditya Shreenivas, et al.
International Journal of Radiation Oncology, Biology, Physics|September 15, 2022
Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular CarcinomaAditya Juloori, Rohan R Katipally, Jeffrey M Lemons, et al.
Annals of Surgery|April 20, 2023
Biliary Adverse Events During Neoadjuvant Therapy for Pancreatic CancerSam Z Thalji, Deemantha Fernando, Kulwinder S Dua, et al.
Cancers|January 28, 2026
Impact of Neoadjuvant Induction Chemotherapy Prior to Chemoradiation on Survival and Surgical Outcomes in Real-World Esophageal Adenocarcinoma CohortThomas M Matoska, Abdullah A Memon, Lou-Anne Acevedo Moreno, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 16, 2014
Diagnostic laparoscopy should be performed before definitive resection for pancreatic cancer: a financial argumentThejus T Jayakrishnan, Hasan Nadeem, Ryan T Groeschl, et al.
Advances in Radiation Oncology|November 10, 2025
Safety and Efficacy of Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy (SMART) for Ultracentral Metastases in Non-Small Cell Lung CancerElena Moreno-Olmedo, Ben George, Kasia Owczarczyk, et al.
Annals of Surgery|October 13, 2018
Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic CancerSusan Tsai, Ben George, David Wittmann, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 2, 2020
Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancerAshley N Krepline, Jennifer L Geurts, Idayat Akinola, et al.
Surgery|July 6, 2019
Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgeryChad A Barnes, Mariana I Chavez, Susan Tsai, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 30, 2017
Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy?Chad A Barnes, Ashley N Krepline, Mohammed Aldakkak, et al.
Therapeutic Advances in Medical Oncology|May 21, 2024
Chemotherapy-free treatment targeting fusions and driver mutations in <i>KRAS</i> wild-type pancreatic ductal adenocarcinoma, a case seriesMaahum Mehdi, Aniko Szabo, Aditya Shreenivas, et al.
International Journal of Radiation Oncology, Biology, Physics|September 15, 2022
Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular CarcinomaAditya Juloori, Rohan R Katipally, Jeffrey M Lemons, et al.
Annals of Surgery|April 20, 2023
Biliary Adverse Events During Neoadjuvant Therapy for Pancreatic CancerSam Z Thalji, Deemantha Fernando, Kulwinder S Dua, et al.
Cancers|January 28, 2026
Impact of Neoadjuvant Induction Chemotherapy Prior to Chemoradiation on Survival and Surgical Outcomes in Real-World Esophageal Adenocarcinoma CohortThomas M Matoska, Abdullah A Memon, Lou-Anne Acevedo Moreno, et al.
Pageof 13